Published in Br J Cancer on December 01, 1999
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 2.21
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis. BMC Cancer (2006) 0.90
The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells. Am J Respir Cell Mol Biol (2009) 0.88
Mesotheliomas in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibres. Carcinogenesis (1981) 1.94
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg (1994) 1.89
Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol (1994) 1.70
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther (1998) 1.29
Biology of human colon cancer metastasis. World J Surg (1995) 1.10
Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene (1997) 1.10
Host organ specifically determines cancer progression. Cancer Res (1995) 1.00
The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat (1994) 1.00
Pleural carcinogenic potency of mineral fibers (asbestos, attapulgite) and their cytotoxicity on cultured cells. J Natl Cancer Inst (1987) 0.98
Gene therapy in the United States: a five-year status report. Hum Gene Ther (1996) 0.94
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol (1995) 0.87
Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Chest (1993) 0.85
Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther (1997) 0.83
Malignant pleural mesothelioma. Crit Rev Oncol Hematol (1997) 0.82
Current progress in the gene therapy of cancer. Curr Opin Oncol (1996) 0.81
Occurrence and morphology of tumors induced in nude mice transplanted with chrysotile-transformed rat pleural mesothelial cells. Biol Cell (1989) 0.79
Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison. Cancer (1991) 0.79
Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer. Lung Cancer (1995) 0.78
[Inhibitors of Ras farnesylation: tomorrow's anticancer agents?]. Bull Cancer (1997) 0.78
Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol (1995) 2.28
Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome. Am J Gastroenterol (1999) 2.14
Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med (2008) 2.05
Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J Infect Dis (1993) 2.04
Mesotheliomas in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibres. Carcinogenesis (1981) 1.94
Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol (1994) 1.70
Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol (1997) 1.67
Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest (2001) 1.62
Analysis of cell cycle disruptions in cultures of rat pleural mesothelial cells exposed to asbestos fibers. Am J Respir Cell Mol Biol (1997) 1.59
The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol (1995) 1.56
SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol (1998) 1.55
Cold abscess of the chest wall: a surgical entity? Ann Thorac Surg (1998) 1.54
Rat pleural mesothelial cells in culture. In Vitro (1981) 1.48
Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology (2006) 1.41
[Evaluation of thoracic surgical practice. The impact of specialisation and the effect of volume on the results of cancer treatment: resectability, post-operative mortality, and long-term survival]. Rev Mal Respir (2006) 1.40
In vitro reactivity of alveolar macrophages and red blood cells with asbestos fibres treated with oxalic acid, sulfur dioxide and benzo-3,4-pyrene. Toxicology (1981) 1.34
Leaching of chrysotile asbestos in human lungs. Correlation with in vitro studies using rabbit alveolar macrophages. Environ Res (1977) 1.33
Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol (1979) 1.30
Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax. Eur Respir J (2007) 1.26
Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells. Mutat Res (1986) 1.21
Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med (1995) 1.20
Culture procedure of mesothelial cells from the rat parietal pleura. Biomedicine (1978) 1.19
Contribution of prostaglandins and thromboxanes to the adenosine and ATP-induced contraction of guinea-pig isolated trachea. Br J Pharmacol (1982) 1.18
In vitro biodegradation of chrysotile fibres by alveolar macrophages and mesothelial cells in culture: comparison with a pH effect. Br J Ind Med (1984) 1.17
Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg (2001) 1.17
Effects of five different organic calcium antagonists on guinea-pig isolated trachea. Br J Pharmacol (1984) 1.16
Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med (1997) 1.15
Thoracoscopic excision of mediastinal bronchogenic cysts: results in 20 cases. Ann Thorac Surg (2000) 1.11
Chemical and photoelectron spectrometry analysis of the adsorption of phospholipid model membranes and red blood cell membranes on to chrysotile fibres. Br J Ind Med (1980) 1.08
Sodium cromoglycate, verapamil and nicardipine antagonism to leukotriene D4 bronchoconstriction. Br J Pharmacol (1983) 1.07
Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res (1997) 1.07
Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev (2001) 1.07
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol (2012) 1.07
Inhibition by phospholipids of haemolytic action of asbestos. Br J Ind Med (1979) 1.06
Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer (2000) 1.06
Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med (1994) 1.04
Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells. Am J Transplant (2007) 1.04
[Prevalence of Enterocytozoon bieneusi spores in the stool of AIDS patients and African children not infected by HIV]. Bull Soc Pathol Exot (1993) 1.02
Secondary alveolar proteinosis in cancer patients. Support Care Cancer (1996) 1.01
Effects of diltiazem and other Ca2+ antagonists on guinea-pig tracheal muscle. Eur J Pharmacol (1983) 1.00
Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. Br J Cancer (2009) 1.00
Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology (1988) 0.99
Effects of Bay K 8644 on contraction of the human isolated bronchus and guinea-pig isolated trachea. Br J Pharmacol (1986) 0.98
Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro. Carcinogenesis (1994) 0.97
In vitro transformation of rat pleural mesothelial cells by chrysotile fibres and/or benzo[a]pyrene. Carcinogenesis (1985) 0.97
CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa. J Histochem Cytochem (2000) 0.97
Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J Immunol (1999) 0.96
An autopsy case of acute multiple sclerosis (Marburg's type) during pregnancy. Clin Neurol Neurosurg (2008) 0.96
First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer (1997) 0.96
[Autonomous intrathoracic goiter. Apropos of 2 new cases]. Rev Pneumol Clin (1986) 0.95
Management of sinonasal hemangiopericytomas. Rhinology (1999) 0.94
Plasma protein immunocytochemistry and polysaccharide cytochemistry at the surface of alveolar and endothelial cells in the rat lung. J Histochem Cytochem (1976) 0.94
Percutaneous parietal pleurectomy for recurrent spontaneous pneumothorax. Lancet (1991) 0.94
Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun (2009) 0.93
Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. Int J Cancer (1998) 0.93
Biological effects of attapulgite. IARC Sci Publ (1980) 0.93
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am J Pathol (2001) 0.92
Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med (1999) 0.92
Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis (1984) 0.92
Dissimilar expression of axonemal anomalies in respiratory cilia and sperm flagella in infertile men. Am Rev Respir Dis (1990) 0.92
The interactions between asbestos fibers and metaphase chromosomes of rat pleural mesothelial cells in culture. A scanning and transmission electron microscopic study. Am J Pathol (1987) 0.92
Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med (1996) 0.92
Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat (2003) 0.92
Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data. Ann Oncol (2012) 0.91
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther (2003) 0.91
Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology. Br J Cancer (1998) 0.91
Kinetics of elimination and acute consequences of cerebral air embolism. J Neuroimaging (1995) 0.90
Surgical treatment of active and sequelar forms of pulmonary tuberculosis. Ann Thorac Surg (2001) 0.90
Immunoelectron microscopic and immunochemical demonstrations of serum proteins in the alveolar lining material of the rat lung. Am Rev Respir Dis (1976) 0.90
Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol (1995) 0.90
Expression of heat shock proteins in human lung and lung cancers. Am J Respir Cell Mol Biol (1994) 0.89
[Esophago-bronchial fistula in adults]. Ann Chir (1990) 0.89
In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line. Prostate (2001) 0.89
Biological in vitro and in vivo responses of chrysotile versus amphiboles. Environ Health Perspect (1983) 0.89
[Mediastinal cysts: clinical approach and treatment]. Rev Pneumol Clin (2010) 0.89
Role of fibre characteristics on cytotoxicity and induction of anaphase/telophase aberrations in rat pleural mesothelial cells in vitro: correlations with in vivo animal findings. Carcinogenesis (1995) 0.89
Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma. Cancer Res (1998) 0.89
Objective voice quality analysis before and after onset of unilateral vocal fold paralysis. J Voice (2001) 0.88
Do nasal ciliary changes reflect bronchial changes? An ultrastructural study. Am Rev Respir Dis (1993) 0.88
Emesis in dogs: a review. J Small Anim Pract (2010) 0.88
Relationship between the number of asbestos fibres and the cellular and enzymatic content of bronchoalveolar fluid in asbestos exposed subjects. Bull Eur Physiopathol Respir (1980) 0.88
Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern. Eur Respir J (1994) 0.88
Effects of mechanical ventilation with normobaric oxygen therapy on the rate of air removal from cerebral arteries. Crit Care Med (1994) 0.87
Effects of well-defined fibres on red blood cells and alveolar macrophages. IARC Sci Publ (1980) 0.87
Thoracoscopic splanchnicectomy for control of intractable pain in pancreatic cancer. Ann Thorac Surg (1998) 0.87
Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol (1993) 0.86
Comparative toxicities of different forms of asbestos on rat pleural mesothelial cells. Environ Health Perspect (1983) 0.86
Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study. Fertil Steril (1997) 0.86
Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem (2000) 0.86